1. A Population Pharmacokinetic Model for Vancomycin in Adult Patients Receiving Extracorporeal Membrane Oxygenation Therapy. (17th September 2016) Authors: Moore, JN; Healy, JR; Thoma, BN; Peahota, MM; Ahamadi, M; Schmidt, L; Cavarocchi, NC; Kraft, WK Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 5:Number 9(2016:Sep.) Page Start: 495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of Vorapaxar Alone and in Combination with Aspirin on Bleeding Time and Platelet Aggregation in Healthy Adult Subjects. Issue 4 (15th June 2016) Authors: Kraft, WK; Gilmartin, JH; Chappell, DL; Gheyas, F; Walker, BM; Nagalla, S; Naik, UP; Horrow, JC; Wrishko, RE; Zhang, S; Anderson, MS Journal: Clinical and translational science Issue: Volume 9:Issue 4(2016) Page Start: 221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Reversibility of Apixaban Anticoagulation with a Four‐Factor Prothrombin Complex Concentrate in Healthy Volunteers. Issue 3 (12th May 2016) Authors: Nagalla, S; Thomson, L; Oppong, Y; Bachman, B; Chervoneva, I; Kraft, WK Journal: Clinical and translational science Issue: Volume 9:Issue 3(2016) Page Start: 176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The Nephrotoxicity of Vancomycin. Issue 3 (5th June 2017) Authors: Filippone, EJ; Kraft, WK; Farber, JL Journal: Clinical pharmacology & therapeutics Issue: Volume 102:Issue 3(2017) Page Start: 459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗